(Total Views: 691)
Posted On: 07/02/2020 10:22:14 AM
Post# of 155819
The science of Leronlimab is almost perfection... what it has been doing and I believe will continue doing is nothing short of 'miraculous'... human data is what all seem to be waiting on but that will come as sure as I'm alive... the manufacturing arm is the real concern to many.
Dr. Nitya G. Ray, PhD... who is Chief Technology Officer - Head of Process Sciences, Manufacturing & Supply Chain... has been closely working with Samsung Biologics to get supply of Leronlimab beefed up, according to Dr. Pourhassan.
The 6/11 CC by CytoDyn is on the website with replay only until 7/11... on that call, Dr. Pourhassan says Dr. Ray has worked out getting the maximum amount of Leronlimab and that he says is 1.5-Million vials this year for treating 375-thousand patients if they get FDA approval... could generate $2.5-billion this year. And he said as much as 6-Million vials in 2021 to generate $9-Billion.
I wonder if... actually imagine... Dr. Ray is involved with NIIMBL, The National Institute for Innovation in Manufacturing Biopharmaceuticals :
https://niimbl.force.com/s/
Dr. Nitya G. Ray, PhD... who is Chief Technology Officer - Head of Process Sciences, Manufacturing & Supply Chain... has been closely working with Samsung Biologics to get supply of Leronlimab beefed up, according to Dr. Pourhassan.
The 6/11 CC by CytoDyn is on the website with replay only until 7/11... on that call, Dr. Pourhassan says Dr. Ray has worked out getting the maximum amount of Leronlimab and that he says is 1.5-Million vials this year for treating 375-thousand patients if they get FDA approval... could generate $2.5-billion this year. And he said as much as 6-Million vials in 2021 to generate $9-Billion.
I wonder if... actually imagine... Dr. Ray is involved with NIIMBL, The National Institute for Innovation in Manufacturing Biopharmaceuticals :
https://niimbl.force.com/s/
(4)
(0)
